Developing Countries Vaccine Manufacturers Network (DCVMN): Engaging to step up for vaccine discovery and access. Meeting Report 2012

Vaccine

Volumn 31, Issue 31, 2013, Pages 3111-3115

  Pagliusi, Sonia ^a   Makhoana, Morena ^b   Datla, Mahima ^c   Leite, Luciana ^d   Hendriks, Jan ^e   Gholami, Alireza ^f   Huang, Weidan ^g   Gao, Yongzhong ^g   Jadhav, Suresh ^h   Harshavardhan, Gutla V J A ⁱ   Wu, Yonglin ^j   Suhardono, Mahendra ^k   Homma, Akira ^l  

^a DCVMN International   (Switzerland)

^b Biovac Institute   (South Africa)

^c Biological e Ltd   (India)

^d INSTITUTO BUTANTAN   (Brazil)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^f PASTEUR INSTITUTE OF IRAN   (Iran)

^g Xiamen Innovax Biotech   (China)

^h Serum Institute of India Ltd   (India)

ⁱ Bharat Biotech International Ltd   (India)

^j China National Biotec Group   (China)

^k PT Biofarma   (Indonesia)

^l INSTITUTO OSWALDO CRUZ   (Brazil)

more..

Author keywords

Infectious diseases; Manufacturing; Public heath; Technology transfer; Vaccine

Indexed keywords

HEPATITIS E VACCINE; ROTAVIRUS VACCINE; VACCINE; HEPATITIS VACCINE;

AFRICA; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; DRUG MANUFACTURE; HEALTH CARE ORGANIZATION; HEPATITIS E; HUMAN; INFECTION; INFORMATION; LEGAL ASPECT; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; TECHNOLOGY; WORLD HEALTH ORGANIZATION; ARTICLE; ECONOMICS; HEALTH; INTERNATIONAL COOPERATION; INVENTION; MENINGITIS; ORGANIZATION; PREVENTIVE HEALTH SERVICE; QUALITY CONTROL; STANDARD; STANDARDS; SUPPLY AND DISTRIBUTION;

AFRICA; CONGRESSES AS TOPIC; DEVELOPING COUNTRIES; HUMANS; IMMUNIZATION PROGRAMS; INTERNATIONAL COOPERATION; INVENTIONS; MENINGITIS; QUALITY CONTROL; TECHNOLOGY TRANSFER; VACCINES; VIRAL HEPATITIS VACCINES; WORLD HEALTH; WORLD HEALTH ORGANIZATION; GLOBAL HEALTH;

EID: 84879076374     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.04.082     Document Type: Conference Paper

References (17)

1. Offit P. The Cutter incident: commentary by Michael Fitzpatrick. J R Soc Med 2006, 99:156. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1383764/pdf/0156.pdf.
2. Science and the regulation of biological products CBER Report 2002, Available at http://www.fda.gov/downloads/AboutFDA/WhatWeDo/History/ProductRegulation/100YearsofBiologicsRegulation/UCM070313.pdf.
3. Jensen M.B., Johnson B., Lorenz E., Lundvall B.A. Forms of knowledge and modes of innovation. Res Policy 2007, 36:680-693. Available at http://hp.gredeg.cnrs.fr/Edward_Lorenz/Papers/RP%202007.pdf.
4. WHO product decisions: a navigation guide. 2011 (page 16) . http://www.ghtcoalition.org/files/WHO_Schematic_vaccines_v01_rev01.pdf.
5. Project OPTIMIZE: rethinking the immunization logistics. http://www.who.int/immunization_delivery/optimize/en/index.html.
6. Taking advantage of the true heat stability of vaccines. Factsheet July 2012. Available at http://www.who.int/immunization_delivery/optimize/true_heat_stability_vaccines.pdf.
7. Presentation to 13th Annual General. Meeting of the DCVMN. UNICEF Vaccine Forecasting. 1 November 2012. Available at . http://www.unicef.org/supply/files/12_11_01_UNICEF_at_DCVMN.pdf.
8. http://www.unicef.org/supply.
9. Meningococcal meningitis: WHO. http://www.who.int/immunization/topics/meningitis/en/index.html.
10. GAVI facts and figures: Statistics measuring the GAVI Alliance's impact on global immunisation. Available at /. http://www.gavialliance.org/advocacy-statistics.
11. Swan P. The economics of standardization. Report for the UK Department of Business, Innovation and Skills (BIS) 2010. Available at . http://www.bis.gov.uk/feeds/~/media/ED32CDA672764D7C8AC2F4E323581010.ashx.
12. Larson H.J., Cooper L.Z., Eskola J., Katz S.L., Ratzanet S. Addressing the vaccine confidence gap. Lancet 2011, 378:526-535.
13. http://www.niaid.nih.gov/.
14. WHO Technical Working Group on creation of an oral cholera vaccine stockpile. Report 2012. Available at . http://apps.who.int/iris/bitstream/10665/75240/1/WHO_HSE_PED_2012_2_eng.pdf.
15. An investment case for the accelerated introduction of oral cholera vaccines. IVI Report 2010. Available at . http://www.ivi.int/publication/IVI_Global_cholera_case.pdf.
16. Ventura R., Brunner L., Heriyanto B., de Boer O., O'Hara M., Huynh C., et al. Technology transfer of an oil-in-water vaccine-adjuvant for strengthening pandemic influenza preparedness in Indonesia. Vaccine 2012, [Epub ahead of print].
17. Hendriks J. Technology transfer in human vaccinology: a retrospective review on public sector contributions in a privatizing science field. Vaccine 2012, 30(44):6230-6240.